Compare Heron Therapeutics Inc (HRTX) vs KLA Corp. (KLAC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs KLA Corp. — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while KLA Corp. trades at $217.14 (market cap $271.18B). The key difference: KLA Corp. is far larger — about 2965× Heron Therapeutics Inc's market cap, and KLA Corp. pays a 0.44% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | KLAC | |
|---|---|---|
Market Cap | $91.46M | $271.18B |
Sector | Health | Technology |
52-Week High | $1.96 | $301.71 |
52-Week Low | $0.39 | $84.39 |
Enterprise Value | $189.36M | $272.37B |
Dividend Yield | — | 0.44% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About KLA Corp.
KLA designs and manufactures yield-management and process-monitoring diagnostic and control systems for the semiconductor manufacturing industry. The systems are used to analyze the manufacturing process at various steps in a semiconductor's development. The firm's laser-scanning products are used for wafer qualification, process monitoring, and equipment monitoring. KLA also provides inspection tools and systems for optical metrology and e-beam metrology.
Read more on KLAC →
